Study Confirms Nasdepi® Dose Enabling Pivotal Biocomparability Study and Commercial Manufacturing RALEIGH, NORTH CAROLINA / ACCESS Newswire / April 15, 2025 / Belhaven Biopharma, a leader in ...

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and ...

ATLANTA, GA / ACCESS Newswire / April 15, 2025 / May is Arthritis Awareness Month, and the Arthritis Foundation, the number one resource for arthritis resources and information, is introducing Green ...

UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at ...

BRIDGEWATER, NJ / ACCESS Newswire / April 15, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the ...

Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the ...

Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, held its Annual General Meeting today. The Annual General Meeting approved the Annual Report, the ...

LAS CRUCES, NM / ACCESS Newswire / April 14, 2025 / Electronic Caregiver, Inc., provider of the groundbreaking Addison Care ...

TAMPA, FL / ACCESS Newswire / April 15, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (the "Company"), a holding company for various existing and planned strategic businesses centered around ...

Dermata previously announced XYNGARI(TM) produced highly statistically significant topline data for all primary endpoints at week 12 in Phase 3 trial -- Additional data analysis revealed that ...

SAN DIEGO, CA / ACCESS Newswire / April 15, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...

Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product ...